BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32109665)

  • 1. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
    Amorós-Pérez M; Fuster JJ
    Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
    Fuster JJ; Walsh K
    Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis and clonal hematopoyesis: A new risk factor.
    Páramo Fernández JA
    Clin Investig Arterioscler; 2018; 30(3):133-136. PubMed ID: 29699715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis - Beyond Conventional Cardiovascular Risk Factors.
    Zuriaga MA; Fuster JJ
    Circ J; 2023 Feb; 87(3):394-400. PubMed ID: 34433749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
    Haybar H; Shahrabi S; Ghanavat M; Khodadi E
    J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
    Huang YC; Wang CY
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
    Jaiswal S; Libby P
    Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal hematopoiesis and vascular disease.
    Amancherla K; Wells JA; Bick AG
    Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors.
    Fuster JJ
    Thromb Res; 2022 May; 213 Suppl 1():S107-S112. PubMed ID: 36210552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
    Menendez-Gonzalez JB; Rodrigues NP
    Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
    Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
    JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer.
    Zuriaga MA; Fuster JJ
    Clin Investig Arterioscler; 2023; 35(1):35-41. PubMed ID: 34879980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
    Fuster JJ; MacLauchlan S; Zuriaga MA; Polackal MN; Ostriker AC; Chakraborty R; Wu CL; Sano S; Muralidharan S; Rius C; Vuong J; Jacob S; Muralidhar V; Robertson AA; Cooper MA; Andrés V; Hirschi KK; Martin KA; Walsh K
    Science; 2017 Feb; 355(6327):842-847. PubMed ID: 28104796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal haematopoiesis is increased in early onset in systemic sclerosis.
    Ricard L; Hirsch P; Largeaud L; Deswarte C; Jachiet V; Mohty M; Rivière S; Malard F; Tenon M; de Vassoigne F; Fain O; Gaugler B; Rossignol J; Delhommeau F; Mekinian A;
    Rheumatology (Oxford); 2020 Nov; 59(11):3499-3504. PubMed ID: 32757002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
    Haring B; Wissel S; Manson JE
    Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
    Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ
    J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis.
    Heyde A; Rohde D; McAlpine CS; Zhang S; Hoyer FF; Gerold JM; Cheek D; Iwamoto Y; Schloss MJ; Vandoorne K; Iborra-Egea O; Muñoz-Guijosa C; Bayes-Genis A; Reiter JG; Craig M; Swirski FK; Nahrendorf M; Nowak MA; Naxerova K
    Cell; 2021 Mar; 184(5):1348-1361.e22. PubMed ID: 33636128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.